RNAscence Biotechnology
PrivateTotal Funding Raised
$2.22M
Company Overview
RNAscence Biotechnology is a biotechnology company that developed a dissolvable micro-tip patch infused with hyaluronic acid and hydrolyzed RNA for scar care.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, D2C Brands
Business Model
B2B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RNAscence Biotechnology Comparables
Compare RNAscence Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tiger Biosciences | 64% | |
| ArrayPatch Ltd | 63% | |
| Alliance Pharma plc | 63% |
RNAscence Biotechnology Funding Rounds
Historical fundraising activity
RNAscence Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Startup SG | Seed |
| co11ab Novena | Seed |
| NTUitive | Seed |
| National Health Innovation Centre Singapore | Seed |
RNAscence Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RNAscence Biotechnology's valuation, stock price, and market status.
Is RNAscence Biotechnology a public or private company?
RNAscence Biotechnology is a private company.
What is the current stock price of RNAscence Biotechnology?
RNAscence Biotechnology is a private company with no public stock price. No recent secondary market data is available.
How much is RNAscence Biotechnology worth (valuation)?
Valuation information for RNAscence Biotechnology is not publicly available.
Can I buy RNAscence Biotechnology stock?
RNAscence Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was RNAscence Biotechnology's last funding round?
Funding round information for RNAscence Biotechnology is not publicly available.
Who are the main investors in RNAscence Biotechnology?
Key investors in RNAscence Biotechnology include Enterprise Singapore, co11ab Novena, NTUitive, National Health Innovation Centre Singapore.
Will RNAscence Biotechnology IPO soon?
No public IPO plans have been announced for RNAscence Biotechnology.
How can I track RNAscence Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RNAscence Biotechnology's secondary market activity and sign up for updates.